These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 14964783)

  • 21. "In silico" design of potential anti-HIV actives using fragment descriptors.
    Varnek A; Solov'ev VP
    Comb Chem High Throughput Screen; 2005 Aug; 8(5):403-16. PubMed ID: 16101580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 3D-QSAR and docking studies on the HEPT derivatives of HIV-1 reverse transcriptase.
    Latha RS; Vijayaraj R; Singam ER; Chitra K; Subramanian V
    Chem Biol Drug Des; 2011 Sep; 78(3):418-26. PubMed ID: 21689378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 4D-QSAR study of HEPT derivatives by electron conformational-genetic algorithm method.
    Akyüz L; Sarıpınar E; Kaya E; Yanmaz E
    SAR QSAR Environ Res; 2012 Jul; 23(5-6):409-33. PubMed ID: 22452710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hybrid canonical-correlation neural-network approach applied to nonnucleoside HIV-1 reverse transcriptase inhibitors (HEPT derivatives).
    Mager PP
    Curr Med Chem; 2003 Sep; 10(17):1643-59. PubMed ID: 12871114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of ant colony optimization in development of models for prediction of anti-HIV-1 activity of HEPT derivatives.
    Zare-Shahabadi V; Abbasitabar F
    J Comput Chem; 2010 Sep; 31(12):2354-62. PubMed ID: 20575016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dihydropyrimidinone-isatin hybrids as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.
    Devale TL; Parikh J; Miniyar P; Sharma P; Shrivastava B; Murumkar P
    Bioorg Chem; 2017 Feb; 70():256-266. PubMed ID: 28160944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure-cytotoxicity relationships for a series of HEPT derivatives.
    Bazoui H; Zahouily M; Sebti S; Boulajaaj S; Zakarya D
    J Mol Model; 2002 Jan; 8(1):1-7. PubMed ID: 12111397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-Based design of [(2-Hydroxyethoxy)methyl]-6-(phenylthio)-thymine derivatives as nonnucleoside HIV-1 reverse transcriptase Inhibitors: From HEPTs to Sulfinyl-substituted HEPTs.
    Hao Q; Wang S; Huang W; Zhang Y; Pannecouque C; De Clercq E; Chen F
    Bioorg Chem; 2022 Sep; 126():105880. PubMed ID: 35649315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predicting anti-HIV activity: computational approach using a novel topological descriptor.
    Gupta S; Singh M; Madan AK
    J Comput Aided Mol Des; 2001 Jul; 15(7):671-8. PubMed ID: 11688947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacophore and structure-activity relationships of integrase inhibition within a dual inhibitor scaffold of HIV reverse transcriptase and integrase.
    Wang Z; Tang J; Salomon CE; Dreis CD; Vince R
    Bioorg Med Chem; 2010 Jun; 18(12):4202-11. PubMed ID: 20576573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonnucleoside HIV-1 reverse-transcriptase inhibitors, part 5. Synthesis and anti-HIV-1 activity of novel 6-naphthylthio HEPT analogues.
    Sun GF; Chen XX; Chen FE; Wang YP; De Clercq E; Balzarini J; Pannecouque C
    Chem Pharm Bull (Tokyo); 2005 Aug; 53(8):886-92. PubMed ID: 16079514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ANN QSAR workflow for predicting the inhibition of HIV-1 reverse transcriptase by pyridinone non-nucleoside derivatives.
    Barzegar A; Zamani-Gharehchamani E; Kadkhodaie-Ilkhchi A
    Future Med Chem; 2017 Jul; 9(11):1175-1191. PubMed ID: 28722475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resistance to 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives is generated by mutations at multiple sites in the HIV-1 reverse transcriptase.
    Buckheit RW; Fliakas-Boltz V; Yeagy-Bargo S; Weislow O; Mayers DL; Boyer PL; Hughes SH; Pan BC; Chu SH; Bader JP
    Virology; 1995 Jun; 210(1):186-93. PubMed ID: 7540784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonnucleoside HIV-1 reverse transcriptase inhibitors: Part I. Synthesis and structure-activity relationship of 1-alkoxymethyl-5-alkyl-6-naphthylmethyl uracils as HEPT analogues.
    Meng G; Chen FE; De Clercq E; Balzarini J; Pannecouque C
    Chem Pharm Bull (Tokyo); 2003 Jul; 51(7):779-89. PubMed ID: 12843582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 2-(Aryl)-3-furan-2-ylmethyl-thiazolidin-4-ones as selective HIV-RT inhibitors.
    Rawal RK; Prabhakar YS; Katti SB; De Clercq E
    Bioorg Med Chem; 2005 Dec; 13(24):6771-6. PubMed ID: 16198576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Computer-aided molecular design of highly potent HIV-1 RT inhibitors: 3D QSAR and molecular docking studies of efavirenz derivatives.
    Pungpo P; Saparpakorn P; Wolschann P; Hannongbua S
    SAR QSAR Environ Res; 2006 Aug; 17(4):353-70. PubMed ID: 16920659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemical structure and correlation analysis of HIV-1 NNRT and NRT inhibitors and database-curated, published inhibition constants with chemical structure in diverse datasets.
    Viira B; García-Sosa AT; Maran U
    J Mol Graph Model; 2017 Sep; 76():205-223. PubMed ID: 28738270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure-activity relationships of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine analogues: effect of substitutions at the C-6 phenyl ring and at the C-5 position on anti-HIV-1 activity.
    Tanaka H; Takashima H; Ubasawa M; Sekiya K; Nitta I; Baba M; Shigeta S; Walker RT; De Clercq E; Miyasaka T
    J Med Chem; 1992 Jan; 35(2):337-45. PubMed ID: 1732552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 3D-quantitative structure-activity relationships of HEPT derivatives as HIV-1 reverse transcriptase inhibitors, based on Ab initio calculations.
    Hannongbua S; Nivesanond K; Lawtrakul L; Pungpo P; Wolschann P
    J Chem Inf Comput Sci; 2001; 41(3):848-55. PubMed ID: 11410067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [HEPT and its related compounds as anti-HIV agents].
    Miyasaka T; Tanaka H; Baba M
    Nihon Rinsho; 1993 Sep; 51 Suppl():200-6. PubMed ID: 7505847
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.